New blood biomarkers reveal how common muscular dystrophy treatment may impair overall growth

In a study published in Scientific Reports, an international, multidisciplinary research team that included Binghamton University researchers identified a set of blood proteins that may explain why the corticosteroid prednisone, although beneficial in treating Duchenne muscular dystrophy (DMD), can interfere with childhood growth and bone health.

≈